Alembic Pharma publishes notice for lost equity share certificate

Compliance View source PDF Explain this filing

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹772.00

prior close

₹782.75

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%+1.4% vs sector

On the reaction day the stock moved 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.0

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9pendingpending+0.6+1.4

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Pharmaceuticals informed NSE and BSE that it published a notice in Business Standard on 28 October 2026 for a registered shareholder whose equity share certificate was lost. No financial figures or replacement certificate details were provided.

Likely market impact

Routine disclosure with no direct impact on Alembic's earnings or share price; it concerns share certificate servicing only.